ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,030 filers reported holding ASTRAZENECA PLC in Q1 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,368 | -5.4% | 286 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $20,469 | +3.1% | 286 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $19,851 | +2.4% | 286 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $19,391 | +21.2% | 286 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $16,000 | -20.0% | 286 | -7.1% | 0.00% | -25.0% |
| Q2 2022 | $20,000 | 0.0% | 308 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $20,000 | 0.0% | 308 | -8.9% | 0.00% | 0.0% |
| Q4 2021 | $20,000 | +17.6% | 338 | +18.2% | 0.00% | 0.0% |
| Q3 2021 | $17,000 | +21.4% | 286 | +20.7% | 0.00% | +33.3% |
| Q2 2021 | $14,000 | +16.7% | 237 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $12,000 | 0.0% | 237 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $12,000 | -7.7% | 237 | 0.0% | 0.00% | -25.0% |
| Q3 2020 | $13,000 | -53.6% | 237 | -55.4% | 0.00% | -55.6% |
| Q2 2020 | $28,000 | +250.0% | 531 | +205.2% | 0.01% | +200.0% |
| Q1 2020 | $8,000 | +14.3% | 174 | +18.4% | 0.00% | -25.0% |
| Q4 2019 | $7,000 | – | 147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
| Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
| Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
| SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
| Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
| ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
| Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
| Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
| GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |